| Note: this study is at multiple sites in North Carolina |
| Study title |
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Adult and Adolescent Patients with Active Eosinophilic Esophagitis |
| Disease or condition |
Eosinophilic Esophagitis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
AK002 or placebo |
| Phase |
2 , 3 |
| Study site 1 |
Duke University |
| Study location |
Durham |
| Principal investigator name and email |
David Leiman, david.leiman@duke.edu |
| Study coordinator name and email |
Nicole Pavlus, nicole.pavlus@duke.edu |
| Phone contact |
203-520-2193 |
| Study site 2 |
University of North Carolina at Chapel Hill |
| Study location |
Chapel Hill |
| Principal investigator name and email |
Evan Dellon, MD, MPH cedas@med.unc.edu |
| Study coordinator name and email |
Kacie Walker, Kacie_Walker@med.unc.edu |
| Phone contact |
919-966-0139 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04322708 |
